Evidence that the COMTVal158Met polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 1, 2008, Pages 10-17

  Van Winkel, Ruud ^a,b   Henquet, Cécile ^b   Rosa, Araceli ^c,d   Papiol, Sergi ^c   Faňanás, Lourdes ^c   De Hert, Marc ^a   Peuskens, Jozef ^a   Van Os, Jim ^b,e   Myin Germeys, Inez ^b,f  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

COMT; Experience sampling method; Gene environment interaction; Psychosis; Schizophrenia; Stress

Indexed keywords

CANNABIS; CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG MISUSE; EMOTIONAL DISORDER; ENVIRONMENTAL FACTOR; EXPERIENCE SAMPLING METHOD; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STRESS;

ADULT; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; MARIJUANA ABUSE; METHIONINE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHOTIC DISORDERS; STRESS; VALINE;

CANNABIS;

EID: 37849038622     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30559     Document Type: Article

References (51)

1. Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP. 2000. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: Dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol- O-methyltransferase (COMT). Mol Psychiatry 5(1):96-100.
2. Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29(11):1943-1961.
3. Blasi G, Mattay VS, Bertolino A, Elvevag B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR. 2005. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 25(20):5038-5045.
4. Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC. 2005. Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol Psychiatry 58(11):901-907.
5. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, et al. 2005. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene x environment interaction. Biol Psychiatry 57(10):1117-1127.
6. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. 2004a. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5):807-821.
7. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. 2004b. Variants in the catechol-O-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 9(10):962-967.
8. Clayton D, Hills M. 1993. Wald tests Clayton D, Hills M, editors. Oxford: Oxford University Press.
9. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Spurlock G, Riley B, Scambler P, Asherson P, et al. 1996. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. Am J Psychiatry 153(2):268-270.
10. Delespaul P. 1995. Assessing schizophrenia in daily life. Maastricht: Universitaire Pers Maastricht.
11. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. 2006. Catechol-O-methyltransferase Val158Met Genotype and Neural Mechanisms Related to Affective Arousal and Regulation. Arch Gen Psychiatry 63(12):1396-1406.
12. Eldreth DA, Matochik JA, Cadet JL, Bolla KI. 2004. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 23(3):914-920.
13. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. 2003. Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13(1):33-41.
14. Escher S, Romme M, Buiks A, Delespaul P, van Os J. 2002. Formation of delusional ideation in adolescents hearing voices: A prospective study. Am J Med Genet 114(8):913-920.
15. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, St Clair D, He L. 2005. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis. Biol Psychiatry 57(2):139-144.
16. Glatt SJ, Faraone SV, Tsuang MT. 2003. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. Am J Psychiatry 160(3):469-476.
17. Goldstein H. 1987. Multilevel models in educational and social research. London: Griffin.
18. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananás L, Drukker M, Ramaekers J, van Os J. 2006. An experimental study of catechol- O-methyltransferase val(158)met moderation of delta-9- tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31(12):2748-2757.
19. Henquet C, Rosa A, Delespaul P, Papiol S, Fananás L, van Os J, Myin-Germeys I. submitted. COMT Val158Met moderation of cannabis-induced psychosis: A momentary assessment study of "switching on" hallucinations in the flow of daily life.
20. Kapur S. 2003. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13-23.
21. Kapur S. 2004. How antipsychotics become anti-"psychotic" - from dopamine to salience to psychosis. Trends Pharmacol Sci 25(8):402-406.
22. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP. 1999. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol-O-methyltransferase (COMT) activity. Am J Med Genet 88(6):628-633.
23. Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, Schulze TG, Reshef A, Blanaru M, Gathas S, et al. 2003. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet Part B 119B(1):35-39.
24. Mandelli L, Serretti A, Marino E, Pirovano A, Calati R, Colombo C. 2006. Interaction between serotonin transporter gene, catechol- O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol [Epub ahead of print] doi 10.1017/S1461145706006882.
25. Mathew RJ, Ho BT, Kralik P, Taylor D, Semchuk K, Weinman M, Claghorn JL. 1980. Catechol-O-methyltransferase and catecholamines in anxiety and relaxation. Psychiatry Res 3(1):85-91.
26. McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48:764-770.
27. Munafo MR, Bowes L, Clark TG, Flint J. 2005. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: A meta-analysis of case-control studies. Mol Psychiatry 10(8):765-770.
28. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. 2001. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 58(12):1137-1144.
29. Myin-Germeys I, Krabbendam L, Jolles J, Delespaul P, van Os J. 2002. Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. Am J Psychiatry 159(3):443-449.
30. Myin-Germeys I, Delespaul P, van Os J. 2005a. Behavioural sensitization to daily life stress in psychosis. Psychol Med 35(5):733-741.
31. Myin-Germeys I, Marcelis M, Krabbendam L, Delespaul P, van Os J. 2005b. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk. Biol Psychiatry 58(2):105-110.
32. Myin-Germeys I, Marcelis M, Krabbendam L, Delespaul P, van Os J. 2005c. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk. Biol Psychiatry 58(2):105-110.
33. Nolan KA, Bilder RM, Lachman HM, Volavka J. 2004. Catechol- O-methyltransferase Val158Met polymorphism in schizophrenia: Differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161(2):359-361.
34. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, Abe K. 1998. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243(1-3):109-112.
35. Olsson CA, Anney RJ, Lotfi-Miri M, Byrnes GB, Williamson R, Patton GC. 2005. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr Genet 15(2):109-115.
36. Oswald LM, McCaul M, Choi L, Yang X, Wand GS. 2004. Catechol- O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: A preliminary report. Biol Psychiatry 55(1):102-105.
37. Park TW, Yoon KS, Kim JH, Park WY, Hirvonen A, Kang D. 2002. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol 12(4):299-303.
38. Reuter M, Hennig J. 2005. Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. Neuroreport 16(10):1135-1138.
39. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L. 2004. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161(6):1110-1112.
40. Sanders AR, Rusu I, Duan J, Vander Molen JE, Hou C, Schwab SG, Wildenauer DB, Martinez M, Gejman PV. 2005. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol Psychiatry 10(4):353-365.
41. Simes R. 1986. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73:751-754.
42. Sim-Selley LJ. 2003. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15(2):91-119.
43. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A. 2005. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25(4):836-842.
44. StataCorp. 2005. Stata/SE 9.0 for Windows. College Station.
45. Stefanis NC, van Os J, Avramopoulos D, Smyrnis N, Evdokimidis I, Stefanis CN. 2005. Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: Tuning rather than improving performance. Am J Psychiatry 162(9):1752-1754.
46. Stein MB, Fallin MD, Schork NJ, Gelernter J. 2005. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30(11):2092-2102.
47. Tsai SJ, Hong CJ, Yu YW, Chen TJ. 2004. Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young Chinese females. Neuropsychobiology 50(2):153-156.
48. Tunbridge EM, Harrison PJ, Weinberger DR. 2006. Catechol- O-Methyltransferase, Cognition, and Psychosis: Val(158)Met and Beyond. Biol Psychiatry 60(2):141-151.
49. Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. 2001. Cannabis induced dopamine release: An in-vivo SPECT study. Psychiatry Res 107(3):173-177.
50. Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, MacGregor S, Kirov GK, Owen MJ, O'Donovan MC. 2005. No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 162(9):1736-1738.
51. Wonodi I, Stine OC, Mitchell BD, Buchanan RW, Thaker GK. 2003. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet Part B 120B(1):47-50.